RA Capital-backed cell therapy player in the neoantigen game grabs a $121M megaround to fund first human studies
There’s more than 1 way to skin a mouse. And anyone who figures out the best way in oncology can open the door to a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
